Additionally, antibodies against IL-17 and IL-17 receptors have been used in the treatment of psoriasis and achieved significant efficacy [56], further revealing the important role of IL-17 mainly produced by Th17 cells in psoriasis. This evidence concerns the gene IL17A and psoriasis.